Monitor upcoming earnings calls for discussion of R&D strategy changes under new CMO. Watch for insider trading activity related to Marshall's potential equity grants. Assess whether increased medical leadership signals acceleration of clinical development programs.
Price Chart
Executive Summary
TriSalus Life Sciences appointed Dr. Richard Marshall as Chief Medical Officer, effective June 29, 2026. He transitions from his current role as Medical Director and will receive a $525,000 annual salary, $250,000 sign-on bonus, and potential equity awards of 120,000 stock options and 60,000 restricted stock units.
Key Facts
- Dr. Richard Marshall appointed Chief Medical Officer effective June 29, 2026
- Marshall transitions from current role as Medical Director (held since January 2025)
- Annual base salary of $525,000 and $250,000 sign-on bonus
- Potential equity award of 120,000 stock options and 60,000 restricted stock units upon board approval
- Eligible for annual bonus up to 50% of base salary and future equity grants
Financial Impact
Initial cash compensation of $775,000 in first year ($525k salary + $250k bonus), with potential additional equity awards valued at approximately $1.8 million based on current stock price
Risk Factors
- Integration risk of new executive into leadership team
- Potential dilution from equity awards
- Increased operating expenses from new executive compensation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-023991 |
| Document: tlsipressrelease-drrichard.htm | 0001628280-26-023991 |
| Document: 0001628280-26-023991-index-headers.html | 0001628280-26-023991 |
| Document: 0001628280-26-023991-index.html | 0001628280-26-023991 |
| Document: 0001628280-26-023991.txt | 0001628280-26-023991 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 29, 2026 25w ago | 8-K | $0.9900 $0.6680 | ▼ −32.53% | ▼ −37.75% | $0.7500 (−24.24%) |
Apr 7, 2026 28w ago | 8-K | $1.19 $1.00 | ▼ −15.97% | ▼ −25.75% | $0.7500 (−36.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers